Cargando…

Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents

Detalles Bibliográficos
Autores principales: Chong, Yong, Tani, Naoki, Goto, Takeyuki, Yonekawa, Akiko, Ikematsu, Hideyuki, Shimono, Nobuyuki, Tanaka, Yosuke, Akashi, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527596/
https://www.ncbi.nlm.nih.gov/pubmed/34687832
http://dx.doi.org/10.1016/j.jinf.2021.10.011
_version_ 1784586099309412352
author Chong, Yong
Tani, Naoki
Goto, Takeyuki
Yonekawa, Akiko
Ikematsu, Hideyuki
Shimono, Nobuyuki
Tanaka, Yosuke
Akashi, Koichi
author_facet Chong, Yong
Tani, Naoki
Goto, Takeyuki
Yonekawa, Akiko
Ikematsu, Hideyuki
Shimono, Nobuyuki
Tanaka, Yosuke
Akashi, Koichi
author_sort Chong, Yong
collection PubMed
description
format Online
Article
Text
id pubmed-8527596
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-85275962021-10-20 Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents Chong, Yong Tani, Naoki Goto, Takeyuki Yonekawa, Akiko Ikematsu, Hideyuki Shimono, Nobuyuki Tanaka, Yosuke Akashi, Koichi J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-03 2021-10-20 /pmc/articles/PMC8527596/ /pubmed/34687832 http://dx.doi.org/10.1016/j.jinf.2021.10.011 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Chong, Yong
Tani, Naoki
Goto, Takeyuki
Yonekawa, Akiko
Ikematsu, Hideyuki
Shimono, Nobuyuki
Tanaka, Yosuke
Akashi, Koichi
Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents
title Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents
title_full Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents
title_fullStr Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents
title_full_unstemmed Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents
title_short Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents
title_sort contrasting specific antibody response to bnt162b2 mrna vaccination in sars-cov-2-naive and previously infected nursing home residents
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527596/
https://www.ncbi.nlm.nih.gov/pubmed/34687832
http://dx.doi.org/10.1016/j.jinf.2021.10.011
work_keys_str_mv AT chongyong contrastingspecificantibodyresponsetobnt162b2mrnavaccinationinsarscov2naiveandpreviouslyinfectednursinghomeresidents
AT taninaoki contrastingspecificantibodyresponsetobnt162b2mrnavaccinationinsarscov2naiveandpreviouslyinfectednursinghomeresidents
AT gototakeyuki contrastingspecificantibodyresponsetobnt162b2mrnavaccinationinsarscov2naiveandpreviouslyinfectednursinghomeresidents
AT yonekawaakiko contrastingspecificantibodyresponsetobnt162b2mrnavaccinationinsarscov2naiveandpreviouslyinfectednursinghomeresidents
AT ikematsuhideyuki contrastingspecificantibodyresponsetobnt162b2mrnavaccinationinsarscov2naiveandpreviouslyinfectednursinghomeresidents
AT shimononobuyuki contrastingspecificantibodyresponsetobnt162b2mrnavaccinationinsarscov2naiveandpreviouslyinfectednursinghomeresidents
AT tanakayosuke contrastingspecificantibodyresponsetobnt162b2mrnavaccinationinsarscov2naiveandpreviouslyinfectednursinghomeresidents
AT akashikoichi contrastingspecificantibodyresponsetobnt162b2mrnavaccinationinsarscov2naiveandpreviouslyinfectednursinghomeresidents